EMA · European Union
zinc — EMA regulatory status
zinc (NULL) regulatory status in the European Union is tracked from public EMA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: EMA approved.
Status snapshot
- Status
- EMA approved
- Brand
- NULL
- Mechanism
- Blocks absorption of copper and induces the production of the copper-binding protein metallothionein.
- Structured fields
- 6
Pharmacology context used for competitive intelligence: Blocks absorption of copper and induces the production of the copper-binding protein metallothionein.. This page is a status aggregation for professional reference — not prescribing advice.
Regional decision snapshot — EMA: approved.
Linked evidence on this spoke: 7 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| EMA | European Union | approved | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| Zinc sulphate | Phase 3 | United Therapeutics Europe | NCT01166815 |
| Zinc sulphate 20 mg | Phase 3 | United Therapeutics Europe | NCT00355043 |
| zinc sulphate dietary supplement | Phase 3 | United Therapeutics Europe | NCT00109551 |
| zinc supplementation | Phase 2 | United Therapeutics Europe | NCT00138047 |
| iron and zinc combined | Approved | United Therapeutics Europe | NCT00470158 |
| Zinc gluconate | Unknown | Grace Therapeutics | NCT02856269 |
| zinc | Unknown | BRIGHT MINDS BIOSCIENCES | NCT00149552 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12077551 | Zinc complex, preparation thereof and use thereof for trerapy of human and animal diseases | US |
| 11713305 | Zinc sensors for in vivo imaging of beta-cell function by MRI | US |
| 11421007 | Zinc finger protein compositions for modulation of huntingtin (Htt) | US |
| 11267832 | Mn(II)-based sensors to detect zinc in vivo with MRI | US |
| 11125741 | Compositions and methods for the detection of zinc | US |
| 9897595 | Compositions and methods for the detection of zinc | US |
| 9757209 | Compositions and methods for dental applications involving zinc-oxide cements | US |
| 9717759 | Modification of CXCR4 using engineered zinc finger proteins | US |
| 9624498 | Methods and compositions for regulation of zinc finger protein expression | US |
| 9284251 | Complex zinc and alpha-chlorocarboxylic acid compounds for treating skin lesions | US |
| 9234016 | Engineered zinc finger proteins for treating trinucleotide repeat disorders | US |
| 9163245 | Compositions for linking zinc finger modules | US |
Related hubs
FAQ
What is the EMA approval status of zinc?
zinc currently shows EMA approved in our European Union regulatory index. Confirm on the official EMA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get zinc regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to zinc?
This spoke lists 7 published programs associated with zinc in our pipeline index.